outcomes

we believe in outcomes based medicine and are committed to publishing our clinical studies and outcomes

colin+banner+white.jpg

our study experience

 

RCTs

addAppointmentIcon@2x.png

We have completed two Randomized Control Trials analysing the effectiveness of our solutions in association with the Department of Respiratory Medicine, Galway, Ireland and the Renal Dialysis Centre Beaumont Hospital, Dublin, Ireland, respectively.

 

We are currently working with Vanderbilt University Medical Center on a clinical trial proposing ‘that structured telenursing can increase quality of life for IPF patients.’

vanderbilt.jpg
 

observational studies

diaryIcon@2x.png

We are currently running an observational study in association with the Department of Respiratory Medicine, Dublin, Ireland to, among other objectives,  assess the acceptability and utility of the patientMpower app in helping IPF patients and their healthcare professional caregivers manage their condition.  

Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis

 

We recently completed a study with Nottingham University Hospital identifying biomarkers of progressive fibrotic lung disease.

nottingham nhs.gif
 

American Thoracic Society (ATS) Publications

At ATS 2018, we presented two publications of observational studies related to IPF.

At ATS 2019, we presented three posters related to long term follow up and Air Quality in Pulmonary Fibrosis

European Respiratory Society (ERS) Publications

ERS-Logo.jpg
its-logo.jpg
 

real world experience

genericProfileIcon.png

We conducted a study with the PF Warriors Support Group on the utility and acceptability of patientMpower. These were the results:

100%.png
‘Using patientMpower had a positive effect on my well-being & daily life.’.png
‘I want to continue using patientMpower after the survey.’  .png
‘I would recommend other people with my condition to use patientMpower.’.png
 

 

partner with us banner.png

partner with us

If you are a healthcare professional or dialysis provider interested in joining our clinical trial programme or commercial pilots, please contact us.

If you are a potential investor, we are currently seeking (define here - series A capital investment), please contact us.